Drugs affecting adrenergic synapses

Содержание

Слайд 2

Слайд 3

In the adrenergic synapses the transmission is mediated by noradrenaline or

In the adrenergic synapses the transmission is mediated by noradrenaline or

norepinephrine (NE). The biosynthesis of NE from tyrosine occurs in the adrenergic neurons (varicosities).
Formation of DOPA and dopamine takes place in the cytoplasm of neurons. Dopamine is converted to norepinephrine under the influence of dopamine hydroxylase in the vesicles.
Norepinephrine in the adrenal medulla turns into adrenaline under the influence of methyltransferase
Слайд 4

Noradrenaline (NE), dopamine and adrenaline are called catecholamines. In presynaptic endings

Noradrenaline (NE), dopamine and adrenaline are called catecholamines.
In presynaptic endings

noradrenaline is in a free state (mobile pool) and in vesicles.
Inactivation of NE via monoamine oxidase (MAO) may regulate prejunctional levels of transmitter in the mobile pool.
Nerve impulses induce the release of NE into the synaptic gap. And NE interacts with its receptors.
Слайд 5

Слайд 6

The action of NE on receptors is short-term. It is mainly

The action of NE on receptors is short-term. It is mainly

caused by the swift uptake (70-80%) by the terminals of the anrenergic fibres. Small amounts of NE undergo extraneuronal uptake by the effector cells (smooth muscles).
Catabolism of NE is controlled by MAO and catechol O-methyltransferase.
Adrenoreceptors are divided into α- and β-subtypes.
Слайд 7

The main α-adrenoreceptors include α1 and α2R. Adrenoreceptors α1 have postsynaptic

The main α-adrenoreceptors include α1 and α2R.
Adrenoreceptors α1 have postsynaptic localization

and α2R are located presynaptically and beyond the synapses.
The main role of the presynaptic α2R is their involvement in the system of negative feedback, controlling the release of NE.
Stimulation of these receptors by NE or other drugs inhibits release of NE from the varicosities.
Слайд 8

Among β-R there are also post-, pre-, and extrasynaptic receptors. Presynaptic

Among β-R there are also post-, pre-, and extrasynaptic receptors.
Presynaptic

β2-R perform positive reverse feedback, stimulating NE release. So, it can be confirmed that β-agonists facilitate the release of the NE and β-antagonists inhibit it.
Слайд 9

Слайд 10

The main effects associated with the stimulation of post-and extrasynaptic adrenoreceptors

The main effects associated with the stimulation of post-and extrasynaptic adrenoreceptors
α1

- adrenoreceptors:
Constriction of vessels of the skin, kidneys, intestines;
Contraction of the radial muscle of iris (mydriasis);
Contraction of myometrium;
Contraction of sphincters of the gastrointestinal tract;
Contraction in the capsule of the spleen;
Decrease of motility and tone of the intestine.
Слайд 11

α2 –adrenoceptor (extrasynaptic): Vasoconstriction; Increased platelet aggregation; Decrease in insulin secretion.

α2 –adrenoceptor (extrasynaptic):
Vasoconstriction;
Increased platelet aggregation;
Decrease in insulin secretion.

Слайд 12

β1 - receptors:

β1 - receptors:

Слайд 13

β2 - receptors: Dilation of vessels of the skeletal muscles, liver,

β2 - receptors:
Dilation of vessels of the skeletal muscles, liver, coronary;
Decrease

in muscle tone of the bronchi;
Decrease in intestinal motility and tone;
Decrease in the tone of myometrium;
Activation of glycogenolysis and lipolysis;
Increase in insulin secretion.
Слайд 14

Слайд 15

Classification Drugs of presynaptic action, affecting release and storage of NE

Classification
Drugs of presynaptic action, affecting release and storage of NE or

sympathomimetics or adrenomimetics of indirect action: Ephedrine
Слайд 16

α and β adrenomimetics: Epinephrine, Norepinephrine; α1: Phenylephrine; α2: Naphazoline, Xylometazoline,

α and β adrenomimetics: Epinephrine, Norepinephrine;
α1: Phenylephrine;
α2: Naphazoline, Xylometazoline,

Oxymetazoline;
β1, 2: Isoprenaline;
β1: Dobutamine;
Β2: Salbutamol, Salmeterol, Fenoterol,
Berodual (ipratropium bromide +fenoterol).
Слайд 17

Epinephrine stimulates all types of AR. It increases the force and

Epinephrine stimulates all types of AR.
It increases the force and

rate of cardiac contractions, increases the stroke and minute volume of the heart, systolic blood pressure. The consumption of oxygen by myocardium is increased also. Hypertensive reaction usually induces reflex bradycardia from the mechanoreceptors of the blood vessels.
E. increases peripheral resistance of the blood vessels because it stimulates α AR, but dilates vessels via stimulation βAR.
Слайд 18

Mean arterial pressure increases.

Mean arterial pressure increases.

Слайд 19

E. relaxes smooth muscles of bronchi, eliminates bronchospasm. E. reduces the

E. relaxes smooth muscles of bronchi, eliminates bronchospasm. E. reduces the

secretion of the bronchial glands, reduces the release of inflammatory mediators (histamine) from mast cells.
E. reduces the tone and motility of gastrointestinal tract, but increases the tone of sphincters.
E. induces the contraction of the splenic capsule.
E. increases neuromuscular transmission.
Слайд 20

E. stimulates glycogenolysis (hyperglycemia occurs, blood concentration of lactic acid and

E. stimulates
glycogenolysis (hyperglycemia occurs, blood concentration of lactic acid and

potassium increases) and
lipolysis (concentration of free fatty acids increases).
Слайд 21

Local effects: E. dilates the pupils (mydriasis) due to the contraction

Local effects:
E. dilates the pupils (mydriasis) due to the contraction of

the radial muscles of the iris and decreases intraocular pressure (production of the intraocular fluid is decreased).
Epinephrine causes spasm of blood vessels of the skin and mucous membranes, reduces exudation and inflammation.
Слайд 22

Duration of action: intravenously - 5-10 min., subcutaneous injections - up

Duration of action: intravenously - 5-10 min., subcutaneous injections - up

to 30 minutes.
Indications for use:
to prolong the effect and reduce the toxicity of local anesthetics;
anaphylactic shock, allergic laryngeal edema;
relief of bronchospasm;
insulin overdose, hypoglycemia;
cardiac arrest, acute heart failure, hypotension.
Слайд 23

Side effects: headache, fear, anxiety, tremor, vomiting, tachycardia, extrasystoles.

Side effects: headache, fear, anxiety, tremor, vomiting, tachycardia, extrasystoles.

Слайд 24

Norepinephrine stimulates predominantly α-adrenergic receptors and to a small extent β-AR.

Norepinephrine stimulates predominantly α-adrenergic receptors and to a small extent β-AR.

It causes severe vasospasm and increases blood pressure (5-10 times stronger than epinephrine). Norepinephrine increases force of heart contractions, stroke volume of the heart, causes a reflex bradycardia (activation of the vagus nerve).
Norepinephrine is administered intravenously with vascular collapse during surgery, intoxication, injuries.
Слайд 25

Слайд 26

Norepinephrine can not be administered subcutaneously due to the possibility of

Norepinephrine can not be administered subcutaneously due to the possibility of

necrosis.
It is contraindicated in hemorrhagic and cardiogenic shock because it causes spasm of arterioles and increases the load on the heart.
Side effects: arrhythmias, headache, breathing disorders.
Слайд 27

Phenylephrine stimulates α1-AR but acts weaker than norepinephrine. It increases arterial

Phenylephrine stimulates α1-AR but acts weaker than norepinephrine.
It increases arterial pressure

and causes reflex bradycardia. But it does not affect the heart.
It is more stable (duration of action after intravenous administration – 20 min; after subcutaneous – 40-50 min). It is effective after oral administration.
Слайд 28

Indications for the use: relief and prevention of shock and collapse,

Indications for the use:
relief and prevention of shock and collapse,


to potentiate the action and reduce the toxicity of local anesthetics,
open-angle glaucoma, conjunctivitis, rhinitis,
hemorrhoids (in suppositories).
Слайд 29

Naphazoline, Oxymetazoline and Xylometazoline constrict the vessels of the nasal mucosa,

Naphazoline, Oxymetazoline and Xylometazoline constrict the vessels of the nasal mucosa,

reduce inflammatory response, exudation.
They are used in rhinitis.
Side effects: irritant effect, atrophy of the nasal mucosa, tolerance.
Naphazoline has an inhibitory effect on the CNS.
Слайд 30

Слайд 31

Isoprenaline stimulates all types of β-AR. It stimulates β1-AR of the

Isoprenaline stimulates all types of β-AR.
It stimulates β1-AR of the

heart and increases the force and rate of cardiac contractions; systolic pressure.
Isoprenaline activates β2-AR of the skeletal muscles vessels. This leads to a decrease in diastolic pressure. The mean arterial pressure is also decreased.
Слайд 32

Слайд 33

The drug facilitates atrioventricular conduction and increases heart automatism.

The drug facilitates atrioventricular conduction and increases heart automatism.

Слайд 34

I. decreases the tone of bronchi, muscles of gastrointestinal tract; causes

I. decreases the tone of bronchi, muscles of gastrointestinal tract; causes

hyperglycaemia.
Indications for use: bronchial spasm, atrioventricular block.
Routes of administration: sublingual, inhalation, intravenous, SC.
Adverse affects: tachycardia, cardiac arrhythmias, headache, tremor.
Слайд 35

Salbutamol, fenoterol, salmeterol stimulate B2-AR. They expand the bronchi and are

Salbutamol, fenoterol, salmeterol stimulate B2-AR. They expand the bronchi and are

used for the prevention and relief of bronchospasm.
They cause relaxation of the uterus, prevent premature labor. They are used in threatened preterm labor.
They cause hyperglycemia, vasodilation, low blood pressure.
Слайд 36

Слайд 37

Dobutamine stimulates β1-AR. It moderately increases heart rate, stroke and minute

Dobutamine stimulates β1-AR.
It moderately increases heart rate, stroke and minute

volume of the heart.
It improves atrioventricular conduction, increases myocardial oxygen consumption.
It is used intravenously drip in acute heart failure.
Слайд 38

Слайд 39

Violates the reverse neuronal uptake of NE; Inhibits MAO; Facilitates and

Violates the reverse neuronal uptake of NE; Inhibits MAO; Facilitates

and increases the release of the mediator in the synaptic gap
Increases the effect of sympathetic nerves on the organs

Ephedrine

Слайд 40

Effects: It stimulates heart function, increases blood pressure, causes a broncholytic

Effects: It stimulates heart function, increases blood pressure, causes a broncholytic

effect, inhibits intestinal peristalsis, dilates pupils.
It acts longer and weaker than epinephrine.
It is absorbed from the gastrointestinal tract and penetrates through the BBB, resistant to MAO action.
Indication for the use: spasm of bronchi, to increase arterial pressure, atrioventricular block, rhinitis, narcolepsy.
Слайд 41

Side effects: tachyphylaxis with frequent use (reduction in norepinephrine storage in

Side effects:
tachyphylaxis with frequent use (reduction in norepinephrine storage in

the varicosities),
tachycardia, increased blood pressure, hyperglycemia,
mental dependence (causes euphoria), excitation, insomnia, tremor, doping effect.
Слайд 42